DMTK Insider Trading
Notice: This stock is marked as potentially delisted. It may not be actively trading.
Insider Ownership Percentage: 5.10%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00
DermTech Share Price & Price History
Current Price: $0.00
Price Change: +0.30 (1.20%)
As of 06/26/2024 09:59 PM ET
DermTech Insider Trading History
DermTech Institutional Trading History
Data available starting January 2016
DermTech, Inc., a molecular diagnostic company, engages in the development and marketing of novel non-invasive genomics tests to aid in the diagnosis and management of melanoma in the United States. The company provides DermTech Melanoma Test (DMT), an innovative non-invasive way to enhance melanoma detection for developing product for non-melanoma skin cancers. It also offers DermTech Smart Sticker, which provides a non-invasively way to collect skin sample including standard care by using scalpel to biopsy suspicious lesions. In addition, it provides research services and technology platform on a contract basis to pharmaceutical companies which use the technology for clinical trials. Further, the company develops gene expression assays for the psoriasis, atopic dermatitis, and aging of the skin to pharmaceutical companies to develop drug products in dermatology; and develop custom gene assays to support the pharmaceutical partners. It sells its products through pathology and oncology practitioners. DermTech, Inc. is headquartered in San Diego, California.
Read More on DermTech
Today's Range
Now: N/A
52 Week Range
Now: N/A
Volume
3,662,300 shs
Average Volume
1,065,175 shs
Market Capitalization
$3.29 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
2.48
Who are the company insiders with the largest holdings of DermTech?